摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2,2-dimethyl-propane-1-sulfonyl)-ethanol | 863100-74-7

中文名称
——
中文别名
——
英文名称
2-(2,2-dimethyl-propane-1-sulfonyl)-ethanol
英文别名
2-(2,2-Dimethylpropylsulfonyl)ethanol;2-(2,2-dimethylpropylsulfonyl)ethanol
2-(2,2-dimethyl-propane-1-sulfonyl)-ethanol化学式
CAS
863100-74-7
化学式
C7H16O3S
mdl
——
分子量
180.268
InChiKey
OPKCOBQGZUWEOH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    62.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
    申请人:MIURA Tomoya
    公开号:US20130085132A1
    公开(公告)日:2013-04-04
    The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.
    本发明提供了一种具有SGLT1抑制活性的下式[Ib]所示的吡唑化合物、或其药物可接受的盐、包含该化合物的药物组合物及其医药用途: 其中每个符号如说明书中所定义。
  • PYRAZOLE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
    申请人:Japan Tobacco, Inc.
    公开号:EP2784074A1
    公开(公告)日:2014-10-01
    A compound of the following general Formula [Ib]: , wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.
    以下通式[Ib]的化合物: 其中各符号与描述中定义的相同;或其药学上可接受的盐。
  • US8846746B2
    申请人:——
    公开号:US8846746B2
    公开(公告)日:2014-09-30
  • [EN] CHEMICAL COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF<br/>[FR] COMPOSES CHIMIQUES POUR L'INHIBITION DE PROLIFERATION CELLULAIRE INDESIRABLE ET LEURS UTILISATION
    申请人:JERINI AG
    公开号:WO2005080406A2
    公开(公告)日:2005-09-01
    The present invention is related to compounds having the formula (I), wherein R1, R2, R3, R4, R5, X1, X2, T, U, V, W, Y and n are as defined in the claims, pharmaceutical compositions comprising the compounds and the use of the compounds for manufacturing a medicament for the use in the treatment of diseases involving an abnormal cell proliferation, an undesired cell proliferation, an abnormal mitosis and/or an undesired mitosis, the disease being selected from neurodegenerative diseases, stroke, inflammatory diseases, immune based disorders, infectious diseases, heart diseases, cardiovascular diseases and cell proliferative diseases.
  • [EN] COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF<br/>[FR] COMPOSES CHIMIQUES POUR L'INHIBITION DE PROLIFERATION CELLULAIRE INDESIRABLE ET LEURS UTILISATION
    申请人:JERINI AG
    公开号:WO2005080406A3
    公开(公告)日:2005-12-01
查看更多